Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2025 ,inter alia, to consider and approve Please find enclosed prior ....
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astec Lifesciences has informed the stock exchanges that its Board of Directors will meet on 29th October 2025. The main agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended 30th September 2025, after these are reviewed by the Audit Committee. The filing is a routine regulatory disclosure under SEBI Listing Regulations. The results will also be made available on the company's website at www.godrejastec.com. No financial numbers or performance details have been disclosed in this notice.
This is a standard pre-results intimation with no new information for shareholders. Investors should wait for the actual Q2/H1 FY26 results to be announced on 29th October 2025 for any meaningful insight into the company's performance.